US FDA grants Priority Review to Mobocertinib of Takeda
Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has granted priority ...
Read moreTakeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has granted priority ...
Read moreOn April 23, 2021, the Food and Drug Administration granted accelerated approval to loncastuximab tesirine-lpyl (Zynlonta, ...
Read moreAmgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for investigational ...
Read moreJazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) has granted Priority ...
Read moreThe U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat ...
Read moreGlenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration ...
Read moreBristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has ...
Read moreU.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.